Raymond James Financial Services Advisors Inc. Sells 14,029 Shares of Tilray Inc (NASDAQ:TLRY)

Raymond James Financial Services Advisors Inc. trimmed its holdings in Tilray Inc (NASDAQ:TLRY) by 9.6% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 132,670 shares of the company’s stock after selling 14,029 shares during the quarter. Raymond James Financial Services Advisors Inc.’s holdings in Tilray were worth $305,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in TLRY. Clear Street Markets LLC bought a new position in Tilray in the 3rd quarter worth approximately $25,000. Lake Street Financial LLC purchased a new stake in shares of Tilray during the 3rd quarter worth approximately $28,000. Great Valley Advisor Group Inc. purchased a new stake in shares of Tilray during the 3rd quarter worth approximately $29,000. Stratos Wealth Advisors LLC purchased a new stake in shares of Tilray during the 3rd quarter worth approximately $31,000. Finally, Simplicity Solutions LLC purchased a new stake in shares of Tilray during the 3rd quarter worth approximately $32,000. 9.35% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several brokerages have recently issued reports on TLRY. Canaccord Genuity Group decreased their price objective on Tilray from $4.25 to $4.00 and set a “buy” rating on the stock in a report on Wednesday, April 10th. Alliance Global Partners upped their price objective on Tilray from $2.25 to $2.75 and gave the stock a “neutral” rating in a report on Friday, April 5th. Finally, CIBC decreased their price target on Tilray from $2.25 to $2.00 and set a “neutral” rating on the stock in a report on Wednesday, April 10th.

Tilray Stock Performance

NASDAQ:TLRY opened at $1.72 on Tuesday. The stock’s fifty day moving average is $1.95 and its 200 day moving average is $1.95. Tilray Inc has a fifty-two week low of $1.50 and a fifty-two week high of $3.40. The firm has a market capitalization of $1.33 billion, a PE ratio of -3.91 and a beta of 2.36. The company has a debt-to-equity ratio of 0.11, a quick ratio of 1.18 and a current ratio of 1.92.

Tilray Company Profile

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.